New NCCN Guidelines outline diagnosis, treatment strategies for MPNs
MPN News | September 30, 2016
NCCN Guidelines document evidence-based consensus-driven management to ensure that all patients receive preventive, diagnostic, treatment, and supportive care services that are most likely to lead to optimal outcomes.
Share your experience-myMPN
MPN News | 9/30/2016
myMPN is the first ever registry for all patients with MPNs. It will be launched in early 2017 and we hope youâ€™ll join in our effort to gather patient information about life with ET, PV and MF. The goals of myMPN are:
CTI reports topline data for PERSIST-2 in the hopes of lifting FDA hold in coming months.
MPN News | August 30th, 2016
CTI BIOPHARMA Announces top-line results from PERSIST-2 Phase 3 trial of Pacritnib for high-risk patients with advanced myelofibrosis
ASH announces seventh-round bridge grant recipients
MPN News | July 21st
MPN Research Foundation congratulates our MPN Challenge grantees Zhijian Qian, a PhD from the University of Illinois at Chicago and Ann Mullally,a MD at The Brigham and Women's Hospital for receiving the 2016 ASH Bridge Grant.
MPN News | March 1, 2014
Anti-fibrotic drug PRM-151 recruiting MF patients across the country
MPN News | July 4, 2016
The PROMOTE site has information on their clinical trial including which sites are actively recruiting people who have myelofibrosis.
Stanford and 23andMe partner on MPN
MPN News | July 5, 2016
Reported in Blood, 726 people with Polycythemia vera, essential thrombocythemia and myelofibrosis were compared to a control group.
Vice President Joe Biden addresses the 2016 ASCO audience
MPN News | June 7, 2016
The Cancer Moonshot is a new push for more teamwork in cancer research and application of innovation.
MPN updates from ASCO 2016
MPN News | June 8, 2016
Updates on clinical trials and research news for PV, ET and MF.
Gilead sponsors observational study on MPNs
MPN News | August 2, 2016
A research project sponsored by Gilead is currently seeking participants for a study about experience with MPN symptoms.
FDA OK's Pacritinib for some patients; Full clinical hold remains
MPN News | March 14, 2016
Pacritinib remains on full clinical hold, but per FDA patients receiving benefit are allowed to receive the drug under a Single Patient IND (SPI)/Compassionate use program.
New research out of UIC suggests racial disparities among those with MPN
MPN News | March 11, 2016
Researchers from the University of Illinois at Chicago have just published a study that demonstrated a difference between Caucasians and non-Caucasians for those with myeloproliferative neoplasms.
Medicare Approves Coverage for SCT
MPN News | February 19, 2016
Medicare has (somewhat) come through for people with Myelofibrosis by agreeing to provide coverage for those who qualify and are in need of a Stem Cell Transplant.
Update: Pacritinib Now on Full Clinical Hold
MPN News | February 10, 2016
The FDA has put the Phase 3 trials of Pacritinib on full clinical hold, noting overall survival results.